SCHEMBL25817867

SCHEMBL25817867

c1ccc(-c2nc(-c3cccc(-c4ccc5cc(-c6ccc7ccccc7c6)ccc5c4)c3)nc(-c3ccc4oc5ccccc5c4c3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.46
PLA2G4A P47712 4/20 0.46
PLA2G10 O15496 1/20 0.46
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 4/20 0.46
KMT2A Q03164 3/20 0.46
HSD17B10 Q99714 3/20 0.46
MEN1 O00255 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
CYP1A2 P05177 2/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 4/20 0.41
HPGD P15428 4/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 2/20 0.41
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
CASP3 P42574 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23233547 0.99 PLA2G2A (0.45) PLA2G2APLA2G4APLA2G10KDM4EALDH1A1
SCHEMBL23920954 0.97 PLA2G2A (0.46) PLA2G2APLA2G4APLA2G10KDM4EALDH1A1
SCHEMBL15501840 0.97 PLA2G2A (0.48) PLA2G2APLA2G4APLA2G10KDM4EALDH1A1
SCHEMBL15501439 0.96 KDM4E (0.44) PLA2G2APLA2G4APLA2G10KDM4EALDH1A1
SCHEMBL21425211 0.96 KDM4E (0.47) PLA2G2APLA2G4APLA2G10KDM4EALDH1A1
SCHEMBL22104549 0.96 KDM4E (0.47) PLA2G2APLA2G4APLA2G10KDM4EALDH1A1
SCHEMBL15501329 0.96 KDM4E (0.47) PLA2G2APLA2G4APLA2G10KDM4EALDH1A1
SCHEMBL23233545 0.96 KDM4E (0.47) PLA2G2APLA2G4APLA2G10KDM4EALDH1A1
SCHEMBL15501610 0.96 KDM4E (0.47) PLA2G2APLA2G4APLA2G10KDM4EALDH1A1
SCHEMBL25796505 0.96 KDM4E (0.47) PLA2G2APLA2G4APLA2G10KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 PLA2G2A 4355/4885PLA2G4A 3970/4885PLA2G10 4127/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 PLA2G2A 4355/4885PLA2G4A 3970/4885PLA2G10 4127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.